GH1 and metabolic dysfunction-associated steatotic liver disease: Recently, several clinical studies have shown that growth hormone deficiency (GHD) is complicated with NAFLD [2, 3] and that growth hormone (GH) replacement therapy improves liver dysfunction [4–6] and histological findings of NAFLD [4, 6], suggesting that GHD is considered as one of the pathological causes for NAFLD.